Lv2
120 积分 2025-05-09 加入
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
2天前
已完结
Inhibitory receptor agonists: Emerging strategies in immune modulation
16天前
已关闭
Engaging PD-1 rescuesregulatory T cell function and inhibits inflammatory T cells in rheumatoid arthritis
1个月前
已完结
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
1个月前
已完结
The relationship between the cytokines TNF and TL1A in rheumatoid arthritis
1个月前
已关闭
The relationship between the cytokines TNF and TL1A in rheumatoid arthritis
2个月前
已关闭
Evolution and trajectory of B-cell targeted therapies in rheumatic diseases
3个月前
已完结
Telitacicept: A novel horizon in targeting autoimmunity and rheumatic diseases
3个月前
已完结
Soluble form of immune checkpoints in autoimmune diseases
4个月前
已完结
Bispecific T cell engager therapy for refractory rheumatoid arthritis
5个月前
已完结
皖公网安备34019202002308
